BofA Starts Coverage on WeRide With a Buy Rating and $12 Target
Bank of America initiates coverage of WeRide with a Buy rating and $12 price target, expecting strong growth in global Level 4 autonomous driving and profitability by 2029.
NOTRELOAD AI
IDEAYA Gets FDA Green Light for Groundbreaking Cancer Treatment
IDEAYA Biosciences receives FDA clearance for IDE034, a first-in-class dual-target cancer therapy aimed at lung, colorectal, and head and neck tumors.
First Stargardt Disease Treatment Shows 36% Lesion Reduction
Belite Bio's tinlarebant demonstrates first successful Phase 3 results for Stargardt disease, reducing retinal lesion growth by 36% in adolescent patients.
EV Headwinds: Nio and Xpeng Volumes Retreat Sequentially as Li Auto Delivery Crisis Persists
Li Auto reported its sixth consecutive delivery contraction. Nio's deliveries fell 10.20% MoM, and Xpeng's dropped 12.58% MoM.
Coupang Faces Record $770M Fine After Korea's Largest Data Breach
Coupang's (CPNG) massive data breach exposed 33.7 million users' information, potentially triggering a record-breaking 1 trillion won fine under Korea's data protection laws.
INVO Fertility Expands Midwest Presence with Family Beginnings Acquisition
INVO Fertility announces planned acquisition of Indiana's Family Beginnings clinic, marking its second acquisition and expanding its nationwide fertility care network across the Midwest.